David N. O'dwyer

David N. O'dwyer

Pulmonary Medicine | Intensive Care Medicine

1500 E Medical Center Dr
Floor 3 Reception C
Ann Arbor, MI 48109

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Toll-like receptor 5 protects against murine lung fibrosis through reduced dysbiosis, and TLR5 deficiency is associated with human IPF.

Toll-like receptor 5 protects against murine lung fibrosis through reduced dysbiosis, and TLR5 deficiency is associated with human IPF.

Journal: Science translational medicine

Published: June 03, 2026

Survival According to Radiomic and Visual UIP Classification in Fibrotic ILD.

Survival According to Radiomic and Visual UIP Classification in Fibrotic ILD.

Journal: Chest

Published: April 14, 2026

Quantitative lung tissue functional analysis for pulmonary adverse event risk assessment prior to thoracic radiotherapy.

Quantitative lung tissue functional analysis for pulmonary adverse event risk assessment prior to thoracic radiotherapy.

Journal: Physics and imaging in radiation oncology

Published: February 17, 2026

Targeted lung Lactobacillus johnsonii intervention alleviates virus-induced fibrosis post-HCT through PD-L1/PD-1 signaling.

Targeted lung Lactobacillus johnsonii intervention alleviates virus-induced fibrosis post-HCT through PD-L1/PD-1 signaling.

Journal: Science advances

Published: January 01, 2026

Characteristics of severe disease in granulomatous lymphocytic interstitial lung disease: a retrospective cohort study.

Characteristics of severe disease in granulomatous lymphocytic interstitial lung disease: a retrospective cohort study.

Journal: ERJ open research

Published: November 18, 2025

Gut microbiota associate with disease severity and survival in idiopathic pulmonary fibrosis.

Gut microbiota associate with disease severity and survival in idiopathic pulmonary fibrosis.

Journal: American journal of respiratory and critical care medicine

Published: September 09, 2025

A Quantitative Imaging Measure of Progressive Pulmonary Fibrosis.

A Quantitative Imaging Measure of Progressive Pulmonary Fibrosis.

Journal: American journal of respiratory and critical care medicine

Published: July 18, 2025

Addressing Knowledge Gaps in the Early Detection of Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation: An Official American Thoracic Society Research Statement.

Addressing Knowledge Gaps in the Early Detection of Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation: An Official American Thoracic Society Research Statement.

Journal: American journal of respiratory and critical care medicine

Published: June 26, 2025

Inflammatory Markers and Microbiome Dysbiosis in Hematopoietic Cell Transplant Recipients with Lung Graft-versus-Host Disease.

Inflammatory Markers and Microbiome Dysbiosis in Hematopoietic Cell Transplant Recipients with Lung Graft-versus-Host Disease.

Journal: Transplantation and cellular therapy

Published: March 11, 2025

Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosis.

Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosis.

Journal: bioRxiv : the preprint server for biology

Published: November 28, 2024

The lung microbiome in interstitial lung disease.

The lung microbiome in interstitial lung disease.

Journal: Breathe (Sheffield, England)

Published: November 13, 2024

Residual interstitial lung abnormalities post-COVID-19 infection appear independent of lung microbiota.

Residual interstitial lung abnormalities post-COVID-19 infection appear independent of lung microbiota.

Journal: ERJ open research

Published: November 07, 2024

Showing 1-12 of 64

Last Updated: 09/26/2026